Amanda Gordon
Impact in
- Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment
- Obstetrics and Gynecology top 5%
- Endometrial and Cervical Cancer Treatments
Papers in
-
- Ovarian cancer diagnosis and treatment 3
-
- Lymphoma Diagnosis and Treatment 4
- Co-authors
- David E. Parkin (2 shared papers)Gordon C. Jayson (2 shared papers)Hani Gabra (2 shared papers)Andrea Hay (1 shared paper)R. Atkinson (1 shared paper)Stuart B. Kaye (1 shared paper)Paul Austin Vasey (1 shared paper)Robert Louis Coleman (1 shared paper)
- Journals
- Blood (4 papers)JNCI Journal of the National Cancer Institute (2 papers)Cancer (1 paper)Journal of Pediatric Hematology/Oncology (1 paper)Neurology (1 paper)
- Partner nations
- United StatesGermanyNetherlands
In The Last Decade
Amanda Gordon
12 papers receiving 823 citations
Amanda Gordon's Hit Papers
Peers
Comparison fields: 5 of 57
- Reproductive Medicine 350
- Obstetrics and Gynecology 102
- Oncology 253
- Genetics 101
- Pathology and Forensic Medicine 97
Countries citing papers authored by Amanda Gordon
This map shows the geographic impact of Amanda Gordon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda Gordon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda Gordon more than expected).
Fields of papers citing papers by Amanda Gordon
This network shows the impact of papers produced by Amanda Gordon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda Gordon. The network helps show where Amanda Gordon may publish in the future.
Co-authors
The 25 scholars most cited alongside Amanda Gordon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Phase III Randomized Trial of Docetaxel-Carboplatin Versus Paclitaxel-Carboplatin as First-line Chemotherapy for Ovarian Carcinoma Hit paper breakdown → | 2004 | 482 |
| 2 | 2005 | 177 | |
| 3 | On behalf of the Scottish Gynaecological Cancer Trials Group. Phase III Randomized Trial of Docetaxel?Carboplatin Versus Paclitaxel?Carboplatin as First-line Chemotherapy for Ovarian Carcinoma | 2004 | 107 |
| 4 | 2013 | 40 | |
| 5 | Efficacy and safety of topotecan in the treatment of advanced ovarian carcinoma. | 1997 | 25 |
| 6 | 2020 | 12 | |
| 7 | 2010 | 9 | |
| 8 | 2023 | 7 | |
| 9 | 2011 | 2 | |
| 10 | 2009 | 2 | |
| 11 | 2013 | 1 | |
| 12 | 2011 | 1 |
About Amanda Gordon
Amanda Gordon is a scholar working on Reproductive Medicine, Pathology and Forensic Medicine, Genetics, Oncology and Hematology, having authored 12 papers that have together received 865 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Ovarian cancer diagnosis and treatment (3 papers), CAR-T cell therapy research (2 papers), CNS Lymphoma Diagnosis and Treatment (2 papers), Multiple Myeloma Research and Treatments (2 papers), Cancer Treatment and Pharmacology (1 paper) and Cancer, Hypoxia, and Metabolism (1 paper). The work is most often cited by research in Reproductive Medicine (350 citations), Obstetrics and Gynecology (102 citations), Oncology (253 citations), Genetics (101 citations) and Pathology and Forensic Medicine (97 citations). Amanda Gordon has collaborated with scholars based in United States, Germany and Netherlands. Frequent co-authors include David E. Parkin, Gordon C. Jayson, Hani Gabra, Andrea Hay, R. Atkinson, Stuart B. Kaye, Paul Austin Vasey, Robert Louis Coleman, J. P. Paul and Timothy D. Browder. Their work appears in journals such as Blood, JNCI Journal of the National Cancer Institute, Cancer, Journal of Pediatric Hematology/Oncology and Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.